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http:WHAT THIS PAPER ADDS
This study demonstrates favorable long-term patency and limb salvage rates of radial artery infrainguinal bypass
grafts. Therefore, in patients in need of challenging revascularization and without suitable autogenous conduit, a
radial artery bypass can be performed safely as a more durable alternative to a prosthetic bypass.Objectives: The superiority of autogenous venous conduits in infrainguinal bypass surgery is well established. In
the absence of suitable leg or arm veins the radial artery can be utilized as an alternative autogenous conduit. In
contrast to cardiac surgery, experience with the radial artery as a conduit for infrainguinal bypass surgery is
limited. The purpose of this study was to review the outcomes of our radial artery bypasses over the last 17 years.
Methods: All radial artery bypasses performed between 1995 and 2012 were identiﬁed from a prospective
database. Patency, limb salvage, and survival were calculated using the KaplaneMeier survival estimate method.
Results: Twenty-nine radial artery bypasses were performed in 28 patients. Median follow-up was 55 months
(range 1e170). Twelve-month primary, assisted primary, and secondary patency rates were 49%, 62%, and 73%
respectively; Both 3-year and 5-year primary, assisted primary, and secondary patency rates were 49%, 56% and
67% respectively. Limb salvage rate was 75% at 1- and 5-year follow-up. Patient survival at 1, 3, and 5 years was
96%, 88%, and 76%.
Conclusions: For patients with need of challenging infrainguinal revascularization without suitable autogenous
venous conduit, a radial artery bypass can be performed safely with favorable long-term patency and limb
salvage rates.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Despite advances in endovascular techniques, infrainguinal
bypass surgery continues to play an important role in
revascularization for peripheral arterial occlusive disease
(PAOD). The superiority of great saphenous vein (GSV)
grafts in infrainguinal bypass surgery is well established.1,2
However, it is not uncommon for patients presenting with
PAOD to have a history of prior varicose vein surgery or
cardiac and/or lower extremity revascularization using one
or both great saphenous veins. In case of absent great
saphenous veins, alternative conduit options are arm vein,
cryopreserved vein, prosthetic, or radial artery (RA). The use
of an arm vein as conduit is an accepted technique with
superior patency rates than prosthetic grafts,3,4 while the
patency results of cryopreserved veins have been disap-
pointing.5 The radial artery (RA) has proven to be a durableesented at the ESVS Scientiﬁc Meeting in Budapest September 2013.
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//dx.doi.org/10.1016/j.ejvs.2014.03.016conduit in cardiac surgery, with (long-term) equal or supe-
rior patency rates over GSV grafts.6e8 However, due to its
short length, unconventional harvesting procedure, and lack
of familiarity among vascular surgeons, the use of the RA
for peripheral revascularization is rare. Reports in the
literature of isolated infrainguinal RA grafts are limited to
case reports of up to three patients.9e11 Limb salvage sur-
gery using a radial forearm ﬂap or radial artery ﬂow-through
graft as a composite distal bypass graft with an overlying
skin ﬂap for wound or ulcer coverage has also been
described, but in relatively small series of up to 10 pa-
tients.12e14 In this paper, we report our experience with RA
bypass grafts for infrainguinal revascularization over a
period of 17 years.METHODS
From 1995 to 2012 we prospectively collected a consecutive
series of patients undergoing infrainguinal reconstruction
for peripheral arterial occlusive disease with RA conduits
under a protocol approved by the local ethics committees.
A retrospective review of patient notes was then under-
taken to capture clinical data, including presenting symp-
toms, investigation ﬁndings, operation details, and follow-
Figure 1. Harvesting of radial artery graft. Incision and dissection in
the groove between brachioradialis and ﬂexor carpi radialis
muscles.
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guinal bypass surgery was an absent or unsuitable vein, but
with increasing experience it was also used as the primary
conduit of choice in a small number of suitable patients.
Radial artery harvest
Prior to harvest of the RA an Allen’s test was routinely
performed. If the hand did not re-perfuse within 5 seconds
upon release of the ulnar artery, the test was considered
positive and the radial artery was not harvested.
The patient is positioned in the standard fashion for
infrainguinal bypass surgery with the arm at 90 degrees
placed on an arm board. The skin of the entire forearm and
arm is prepared with alcoholic iodine solution and the handFigure 2. Harvesting of radial artery graft. (A) Clipping of side branch
Injection of papaverine solution into distal end of pedicle. (D) Proximawrapped in a sterile drape. A linear incision is made in the
supine forearm 2 cm below the midpoint of the elbow
crease to approximately 2 cm above the wrist crease, where
the radial pulse is felt (Fig. 1). The radial pedicle lies in a
groove between brachioradialis muscle laterally and the
ﬂexor carpi radialis medially (Fig. 1). The RA with its venae
comitantes is then mobilized using the “no-touch tech-
nique”, to minimize spasm. Side branches are divided be-
tween metal clips (Fig. 2A). The distal RA is doubly clipped
at the wrist and divided 2 cm proximal from the wrist joint
to preserve collateral circulation (Fig. 2B). The arterial
pedicle is kept moist by spraying a solution of papaverine in
ringer lactate (30 mg in 20 mL e 3.2 mmol/L e mixed with
an equal volume of heparinized blood to buffer the acidity
of the papaverine). Part of the solution is injected retro-
gradely into the RA (Fig. 2C) and the distal end of the artery
is clipped. The RA pedicle is then mobilized proximally all
the way to within 1 cm of the bifurcation of the brachial
artery and doubly clipped and divided (Fig. 2D). The ulnar
artery at its origin is left undisturbed. The interosseal artery
usually originates from the ulnar artery, and is therefore
preserved. If it is encountered coming off the proximal
radial artery, it is preserved by clipping the radial artery
distally to it. The radial pedicle is then stored in the
papaverine solution until ready for use. The wound is closed
in two layers with or without a drain as required. To prevent
RA spasm, patients were prescribed 10 mg of amlodipine
twice daily for 3 months postoperatively, unless contra-
indicated. Furthermore, patients were routinely prescribed
a single anti-platelet agent.
Follow-up was performed postoperatively at 1, 3, 6, and
12 months and annually thereafter. Patency was routinely
assessed by clinical examination, ankleebrachial indices,es of radial artery (RA) pedicle. (B) Distal RA pedicle clipping. (C)
l RA pedicle clipping.
Table 1. Patient demographics.
Characteristic Number (%)
Male 10 (36)
Hypertension 15 (56)
Hypercholesterolemia 13 (48)
COPD 5 (19)
Diabetes mellitus 8 (30)
Hemodialysis 2 (8)
Cardiac failure 5 (19)
Ischemic heart disease 14 (52)
Current/ex-smoker 20 (71)
COPD ¼ chronic obstructive pulmonary disease.
82 B.M.E. Mees et al.and duplex ultrasound with selective use of computed to-
mography (CT) angiography and digital subtraction angiog-
raphy, according to the same protocol as for our vein grafts.
Follow-up data were obtained from the surgeon’s database,
hospital records, and outpatient notes. All deﬁnitions and
categories were from the Ad Hoc Committee on Reporting
Standards appointed by the Society of Vascular Surgery, and
the North American chapter of the International Society of
Cardiovascular Surgery.15 The protocol was approved by the
ethics committee of Austin Health.Table 2. Bypass characteristics per patient.
Age
sex
Indication Previous
revascularization
Conduit
48F Tissue loss No L RA
78M Threatened bypass FPBG with GSV R RA
74F Claudication No R RA
72F Claudication No R RA
65F Tissue loss FPBG L RA, cephalic
73F Claudication No L RA
90M Tissue loss No L RA, GSV
57M Claudication No R RA
58M Tissue loss FPBG with GSV R RA
73F Tissue loss No R RA
69M Rest pain FPBG with GSV L RA, cephalic
76F Rest pain No R RA, GSV
87F Tissue loss Pop to DP bypass R RA, cephalic
90F Tissue loss No R RA, cephalic
74F Claudication FPBG with GSV R RA
84F Tissue loss No L RA
74F Rest pain FPBG with GSV R RA, cephalic
77M Claudication FPBG with GSV L RA
75F Claudication FPBG with GSV L RA
72F Claudication No L RA
76F Tissue loss FPBG with GSV L RA
73M Tissue loss FPBG with GSV, arm
vein skip graft to PTA
L RA, bilat bas
70M Acute limb ischemia SFA to TPT bypass
with GSV
R RA
74M Threatened bypass SFA to TPT bypass
with GSV
L RA
74M Tissue loss No R RA
72M Tissue loss No R RA
67M Threatened bypass Fem to PA bypass L RA
78M Tissue loss FPBG with GSV L RA, basilic ve
74F Rest pain FPBG with GSV L RA
FPBG ¼ femoropopliteal bypass graft; GSV ¼ greater saphenous vein;Graft patency (primary, assisted primary and secondary),
limb salvage, and survival were calculated using the Kaplane
Meier survival estimate method. Comparison between sur-
vival curves was performed using the log-rank test for sig-
niﬁcance. All calculations and plots were carried out using
the GraphPad Prism statistical program (GraphPad Software,
California, USA). A p value <.05 was considered signiﬁcant.RESULTS
Over a 17-year period we performed 29 infrainguinal re-
constructions with radial artery grafts in 28 patients at four
Melbourne hospitals (The Austin, The Western, The North-
ern, and Epworth Hospitals). Mean age of the study pop-
ulation was 73 years (range 48e90 years). Patient
demographic data are presented in Table 1. The indication
for revascularization was critical limb ischemia (CLI; 59%),
threatened bypass graft (10%), acute limb ischemia (ALI;
3%), or disabling claudication (28%, Table 2). RA grafts were
selected due to the absence of suitable leg or arm vein
(86%) or as the primary conduit of choice (14%). Causes for
unavailability of the GSV were previous infrainguinal bypass
(48%), previous coronary artery bypass graft (CABG) (14%),Inﬂow Outﬂow Duration
of patency
(months)
Patent Limb
salvage
ATA DP 47 Yes Yes
GSV graft BK pop 33 Yes Yes
PFA AK pop 2 Yes Yes
PFA AK pop 88 Yes Yes
vein SFA TPT 2 Yes No
PFA AK pop 0.1 No No
SFA PA 3 Yes Yes
SFA BK pop 1 Yes Yes
GSV graft AK pop 33 Yes Yes
PFA AK pop 32 No Yes
vein SFA ATA 6 Yes Yes
SFA AK pop 23 Yes Yes
vein BK pop DP 6 No Yes
vein SFA BK pop 59 Yes Yes
GSV graft BK pop 2 No Yes
BK pop PA 30 Yes Yes
vein PFA PTA 11 No Yes
GSV graft PA 54 Yes Yes
GSV graft BK pop 94 Yes Yes
PFA AK pop 170 Yes Yes
SFA BK pop 0.6 Yes Yes
ilic vein PFA PTA 0.7 No No
GSV graft PA 98 Yes Yes
GSV graft RA bypass
graft
68 Yes Yes
SFA AK pop 19 Yes Yes
PTA PTA 8 Yes No
GSV graft ATA 0.1 No No
in SFA PTA 0.2 No No
GSV graft PA 26 Yes Yes
RA ¼ radial artery.
Figure 3. Radial artery (RA) graft patency. KaplaneMeier curve of
ﬁve-year primary patency (PP), assisted primary patency (APP) and
secondary patency (SP) of RA grafts.
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(10%). Thirteen (45%) infrainguinal RA bypasses were “pri-
mary” (ﬁrst infrainguinal bypass for that limb) and 16 by-
passes (55%) were “redo” operations (Table 2).
Graft characteristics
The average length of harvested RA grafts was 20 cm and
the average diameter was 3.1 mm. The conduit was a single
length of RA in 69% and RAevein composite graft in 31% of
patients (Table 2). Inﬂow vessel for the RA graft was the
superﬁcial femoral artery (31%), profunda femoris artery
(24%), previous vein graft (31%), popliteal artery (7%), or a
tibial artery (7%). Outﬂow artery was the above-knee
popliteal artery (28%), the below-knee popliteal artery
(20%), a tibial artery (45%), or a pedal artery (7%, Table 2).
Mean follow-up until death or end of study was 55 months
(range 1e170 months).
Mortality and complications
There were no deaths within 30 days. There was one
complication from the RA harvest (hematoma; 3%). Wound
infections at the bypass site occurred in three patients
(10%). Other complications included acute myocardial
infarction in one patient (3%), arrhythmia in two patients
(7%), and pneumonia in three patients (10%). There were
two cases of peroneal nerve neuropraxia (7%).
Patency
Patency data are presented in Tables 2 and 3 and Fig. 3.
There were ﬁve early graft occlusions (<30 days), with two
grafts successfully thrombectomized and revised. These
grafts remained patent throughout complete follow-up
without any re-interventions. In the ﬁrst year post-
operatively there were three additional graft occlusions,
which were left untreated. All grafts that maintained pri-
mary patency at 12 months remained patent without
reinterventions during the complete study follow-up with
the longest running graft free from reintervention at 14
years’ follow-up (Fig. 4). There was a trend to improved
graft patency in claudication, primary operations, popliteal
bypasses, two or more outﬂow vessels, and single RA
conduits, but none of these reached statistical signiﬁcance
(data shown in Online Data Supplement).
Limb salvage and survival
Six patients (21%) had a major amputation (one above
knee, ﬁve below knee). Four early graft failures resulted inTable 3. Radial artery graft patency and limb salvage.
1 year 3 years 5 years
PP (95% CI) 49% (29e68) 49% (29e68) 49% (29e68)
APP (95% CI) 62% (44e81) 56% (36e77) 56% (36e77)
SP (95% CI) 73% (56e90) 67% (46e87) 67% (46e87)
LS (95% CI) 75% (56e94) 75% (56e94) 75% (56e94)
PP ¼ primary patency; APP ¼ assisted primary patency;
SP ¼ secondary patency; LS ¼ limb salvage.limb loss. Two patients underwent amputation for sepsis in
the setting of a patent graft at 2 and 8 months post-
operatively. Limb salvage data are presented in Tables 2 and
3. Patient survival at 1, 3, and 5 years was 96%, 88% and
76% respectively. Median survival was 55 months.Reintervention
There were 12 reinterventions in 10 grafts. Five throm-
bectomies were performed for acute graft occlusion.
Two balloon angioplasties were performed for radial
artery spasm within the same admission, of which one
was complicated by a hematoma needing evacuation
(Fig. 5). Four graft stenoses (3 vein graft stenoses in a
composite graft and 1 radial artery graft stenosis) were
detected on surveillance and treated with a balloon an-
gioplasty, patch angioplasty or interposition grafting (2
patients).DISCUSSION
RA conduits are commonly used in CABG surgery and have
patency rates that are equal or superior to GSV grafts.6e8
Infrainguinal revascularization with RA conduit has rarely
been described and the literature is limited to case reports
or small series.9e14 Widespread use of RA conduits in
infrainguinal bypass surgery has been limited by the relative
short length of the RA and its propensity to spasm, lack of
familiarity with RA harvest, and lack of awareness among
vascular surgeons. In this report we describe our experience
and results of 29 RA bypass grafts for lower extremity
revascularization.
In our patient cohort the percentage of male patients
(36%) and patients with diabetes (29%) appears lower than
in comparable series on non-GSV infrainguinal bypass sur-
gery.16 A possible explanation for this could be a combi-
nation of the small total number of patients in this cohort
(28), the inclusion of patients with claudication in contrast
to other series, the observation that all previous varicose
vein surgery was in women, and the use of RA as primary
conduit (also all in women). However, percentages
Figure 4. Primary patency of profunda-popliteal radial artery bypass. Recent computed tomography angiography of left profunda-popliteal
bypass with left radial artery graft, which was performed in 1998 for critical limb ischemia. Currently, patient is still asymptomatic with
running graft without any reinterventions during 14 years of follow up.
84 B.M.E. Mees et al.of smokers, patients with ischemic heart disease, and pa-
tients with hemodialysis were comparable with other co-
horts.16e18
The long-term patency and limb salvage (5-year primary
patency 49%, primary assisted patency 56%, secondary
patency 67%, and limb salvage 75%) of our RA bypass grafts
were comparable with or superior to previously reported
patency rates of arm vein bypass grafts.2e4,16,17 However,
the upper extremity veins in patients with extensive pe-
ripheral arterial occlusive disease may also have been used
for previous bypass surgery or often damaged from years ofmultiple punctures or cannulations, rendering them useless
for bypass grafting. The results of our RA bypass series
suggest that the RA can be used as a durable alternative for
arm vein. In comparison with prosthetic grafts, the patency
and limb salvage rates of the RA grafts in our series appear
superior. Three-year primary and secondary patency and
limb salvage rates of RA grafts in this series were compa-
rable but mostly superior to pooled 2-year patency and limb
salvage rates of prosthetic grafts with or without vein cuff
reported in recent Cochrane systematic reviews.2,19 Five-
year patency and limb salvage rates of RA grafts were
Figure 5. Postoperative spasm in profunda-popliteal radial artery (RA) bypass graft. Left: Angiographic images before treatment,
demonstrating mid RA graft spasm. Right: Angiographic images after balloon angioplasty with good result.
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below- and above-knee femoropopliteal bypasses in recent
meta-analyses.20e22
While the subgroup analyses of patency and limb salvage
in our study (data shown in Online Data Supplement) did
not reach statistical signiﬁcance due to the small numbers
they seemed to indicate that, similar to venous bypass
surgery, the indication for revascularization, previous
bypass, target artery, run off, and graft splicing affect
patency. In our series 28% of RA grafts were performed for
the indication of intermittent claudication. The subgroup
analysis of patency and limb salvage suggested better
patency in patients with claudication. The primary and
secondary patency rates at 5 years of follow-up in both our
claudication as CLI groups are comparable or slightly su-
perior to patency rates of prosthetic grafts but inferior to
GSV grafts of a recent meta-analysis.21 One claudicant
suffered limb loss almost 5 years after the RA graft blocked
in the postoperative period (and was left untreated). The
number of claudicants was small (n ¼ 8), but these results
may lead to a discussion whether a RA bypass should be
used for revascularization of patients with intermittent
claudication. The same is true for the results of RA bypass
used as a “primary” conduit. We have performed four RA
grafts as the primary conduit. The ﬁrst graft was an anterior
tibial to dorsalis pedis bypass, which was still (primary)
patent at last follow-up. Three grafts were profunda to
above-knee popliteal bypasses; one of these grafts occluded
and another had an angioplasty for spasm. Two were still
patent at last follow-up. The occluded graft was left un-
treated and this patient lost the limb almost 5 years later. In
this small group of “primary” RA conduits the primary
patency rate (60%) at 5-year follow-up was inferior than
primary patency rates of GSV in a recent meta-analysis, but
secondary patency rates were comparable.21 However, our
limb salvage rate of 50% at 5 years of follow-up and the
small number of patients make it difﬁcult to recommend
use of RA as a primary conduit.In the subgroup analysis for primary or “redo” bypass
surgery, there was a signiﬁcant trend towards increased
long-term primary patency in patients with primary surgery
versus secondary bypass. This reﬂects the reality that a
“redo” bypass can be regarded as secondary patency of the
previous bypass and may already have a compromised
outﬂow. The same trend (although not as signiﬁcant) to-
wards better patency of grafts anastomosed onto the
popliteal artery versus a tibial artery and grafts with two
vessel outﬂow versus one vessel outﬂow was demonstrated
in the subgroup analyses of different target vessels and
outﬂow.
Because of its relatively short length, we utilized isolated
RA grafts for short infrainguinal bypasses, such as profunda
to popliteal, popliteal to pedal or skip grafts from a previous
bypass onto a tibial artery. When a longer length was
required a composite RA with an arm or GSV graft was
used. The RA graft was always used for the distal part of the
composite grafts. In the subgroup analysis, patency rates of
single RA grafts trended towards superiority over patency
rates of RA composite grafts, which may be explained by
the longer bypass length but is in concordance with previ-
ously published superior results of single arm vein grafts
versus spliced arm vein grafts.4
One of the challenges in RA bypass grafting is to avoid
early graft spasm and failure. In our series we experienced
ﬁve graft occlusions within 30 days postoperatively.
Contributing factors to these early graft occlusions could
have been poor outﬂow (4 patients had tibial bypass with
single vessel run-off), type, and length of graft (2 composite
grafts), technical problems and/or RA spasm. Spasm is a
common early complication of RA grafts, which is well
described in the cardiac literature.23e25 To decrease the risk
of RA spasm, ﬁrstly, it is essential to perform a careful “no-
touch” dissection. Secondly, the RA graft should be pre-
pared intra-operatively with a buffered solution to induce
vasodilation. Several pharmacological agents have been
utilized intra-operatively to prevent spasm, but there is no
86 B.M.E. Mees et al.consensus on which is the optimal agent. A recent review
suggested that preparing the graft with a verapamileglyc-
erine trinitrate solution would theoretically achieve optimal
results extrapolated from the biological properties of this
combination of agents.26 In our protocol, RA grafts were
prepared with a buffered papaverine solution, which is a
widely used agent and is regarded by many as the gold
standard.25 Thirdly, postoperative treatment with calcium
channel blockers has been suggested to decrease RA graft
spasm (after CABG); hence, we routinely prescribed amlo-
dipine for 3 months postoperatively to our patients.25,27 If
RA spasm occurs in the postoperative period despite the
above measures, balloon angioplasty is an invasive treat-
ment option, which has proven effective and durable
without re-stenoses in our patient cohort (Fig. 5). The 1-
year primary patency rate of 49% remained unchanged
during follow-up up to 5 years, suggesting that RA grafts can
be very durable, if early graft failure is avoided (Fig. 4).
A potential disadvantage of the use of the RA for
infrainguinal bypass surgery is the loss of a conduit for
future possible life-saving CABG in patients without an
available venous conduit. However, limb salvage in patients
with CLI by revascularization using RA bypass may also be a
life-saving procedure. Patients with CLI have a 1-year mor-
tality of 25% and projected 2-year mortality of 40e50% and
a 1-year major amputation rate of 30%.28 Moreover, in our
study around half of the patients had (treated) ischemic
heart disease and a subset had already undergone CABG.
We also treated elderly patients who would not be candi-
dates for coronary bypass surgery. The survival in our pa-
tient cohort at 5 years’ follow-up was 75%. Therefore, we
believe that a RA graft does not have to be withheld from a
patient with CLI and absent venous conduits who is in need
of revascularization.
In conclusion, our series is the largest reported series of
RA grafts for infrainguinal revascularization and demon-
strates that RA graft is a feasible and durable conduit in
case of absent GSV or arm vein. In our opinion, this tech-
nique should therefore be in the armamentarium of a
vascular surgeon.
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